Table 3.
HERV sequence | E pol | W env | R pol-env | H env 62 | K env | K10 gag | |
---|---|---|---|---|---|---|---|
ANA titre | rs | –0.25 | –0.21 | –0.16 | –0.03 | –0.14 | 0.08 |
P-value | 0.13 | 0.22 | 0.35 | 0.87 | 0.43 | 0.63 | |
Disease duration | rs | 0.10 | 0.20 | 0.07 | 0.03 | 0.10 | –0.04 |
P-value | 0.55 | 0.23 | 0.70 | 0.85 | 0.57 | 0.82 | |
LoSSI | rs | 0.07 | –0.15 | –0.08 | –0.01 | –0.05 | –0.10 |
P-value | 0.70 | 0.40 | 0.66 | 0.95 | 0.79 | 0.60 | |
Age | rs | 0.17 | 0.21 | 0.11 | 0.31 | 0.25 | 0.23 |
P-value | 0.33 | 0.23 | 0.52 | 0.06* | 0.15 | 0.17 | |
Sex | P-value | 0.82 | 0.27 | 0.90 | 0.21 | 0.50 | 0.55 |
Disease activity | P-value | 0.99 | 0.37 | 0.45 | 0.99 | 0.29 | 0.72 |
P-values of U tests are presented for sex and disease activity.
An instance close to statistical significance is marked.